orlistat.txt CLINICAL USE Adjunct in obesity DOSE IN NORMAL RENAL FUNCTION 120 mg taken immediately before, during or up to 1 hour after each meal; maximum 360 mg daily PHARMACOKINETICS Molecular weight                           :495.7 %Protein binding                           :>99 %Excreted unchanged in urine     : 0–4 Volume of distribution (L/kg)       :No data half-life – normal/ESRD (hrs)      :1–2/unchanged DOSE IN RENAL IMPAIRMENT GFR (mL/MIN) 20 to 50     : Dose as in normal renal function 10 to 20     : Dose as in normal renal function <10           : Dose as in normal renal function DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES CAPD                :Unlikely to be dialysed. Dose as in normal renal function HD                     :Unlikely to be dialysed. Dose as in normal renal functionHDF/high flux   :Unlikely to be dialysed. Dose as in normal renal functionCAV/VVHD      :Unlikely to be dialysed. Dose as in normal renal function IMPORTANT DRUG INTERACTIONS Potentially hazardous interactions with other drugsAcarbose: avoid concomitant administration Anticoagulants: monitor INR more frequently Ciclosporin: possibly reduces absorption of ciclosporinVitamins: may reduce the absorption of fat soluble vitamins ADMINISTRATION Reconstition– Route Oral Rate of Administration –Comments– OTHER INFORMATION If the meal doesn’t contain any fat, omit orlistatOrlistat is poorly absorbed; bioavailability of less than 5%. Tags: post-by-auto-php Continue Reading Previous Previous post: naproxen.txtNext Next post: orphenadrine hydrochloride.txt Related News sotalol hydrochloride.txt tazocin.txt